Securing market access is integral to optimal product development, commercialization, and life cycle planning. We collaborate with life sciences clients to help develop and integrate market access insights into clinical and commercial decision-making.
We combine health economic expertise with knowledge of local and regional markets, and build upon that experience with healthcare modeling and analysis, to identify and substantiate value drivers for products in development. Through stakeholder mapping and highlighting unmet needs, analyses of funding flows and third-party payment policy analysis, and value proposition optimization, we assist clients in defining and developing differentiated products through our value substantiation and quantification solutions.
Global and U.S. Specific Strategy, Evaluation, and Planning Solutions:
Stakeholder mapping/funding flow analysis
Value proposition optimization/evidence planning
Strategic Reimbursement Assessments (SRAs) including third-party coverage, coding, and payment landscaping